The protective effects of trimetazidine on normothermic ischemic myocardium in rats
The protective effects of trimetazidine on postischemic cardiac function were studied using isolated working rat heart preparations in which global ischemia had been induced with normothermic cardioplegia. After 30 minutes of reperfusion, following a 25 minutes period of ischemia, the addition of 10−6 M or 10−5 M trimetazidine to the cardioplegic solution significantly increased the per cent recovery of the cardiac output: from 54.8±4.1 per cent in the control group to 81.0±3.2 per cent (p<0.01) and 79.6±4.0 per cent (p<0.01), respectively, although lower (10−7 M) or higher (10−4 M) doses of the drug failed to result in any change. 10−5 M trimetazidine also produced a significantly greater recovery of both the postischemic aortic flow: from 47.8±4.9 per cent to 72.2±3.8 per cent (p<0.01) and the coronary flow: from 80.6±2.9 per cent to 105.2±6.3 per cent (p<0.002). However, trimetazidine did not influence the recovery of either aortic pressure or heart rate. These results suggest that trimetazidine does give some protection to the heart during ischemia and reperfusion.
Key Wordstrimetazidine myocardial protection ischemia reperfusion cardioplegia
Unable to display preview. Download preview PDF.
- 4.Maridonneau-Parini I, Harpey C, Finardi G. Effects of vastarel 20 mg on membrane changes induced by oxygenated free radicals in human erythrocytes. Gaz Med 1984; 91: 63–67.Google Scholar
- 5.Yasunaga K, Kanzaki M, Kimura M, Fujii T, Sato T. Inhibitory effects of trimetazidine hydrochloride on the platelet aggregation. Jpn Arch Int Med 1980; 21: 1–8. (in Japanese)Google Scholar
- 6.Gauduel Y, Duvelleroy MA. Role of oxygen radicals in cardiac injury due to reoxygenation. J Mol Cell Cardiol 1984; 16: 549–570.Google Scholar